CClinicalTrials.gg
CompletedNCT04125173Updated Dec 7, 2021

Effect of Lower Pneumoperitoneum Pressure During Laparoscopic and Robotic Hysterectomy

An interventional study of Pneumoperitoneum pressure = 15mmHg and Pneumoperitoneum pressure = 12mm Hg in Hysterectomy and Pneumoperitoneum, sponsored by University of Arizona. Completed at 1 site in United States. Open to female participants aged 18 Years to 99 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-12-07.

Sponsored by University of Arizona · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 99 Years
Sex
Female
01

Study summary

With the limited evidence that lower pneumoperitoneum pressures improve postoperative pain in laparoscopic or robotic hysterectomy for benign indications, we would like to determine if we can both further validate this idea but also show that it has minimal effect on physician satisfaction performing the surgery.

Read the detailed description

Minimally invasive hysterectomy, including conventional laparoscopic and robotic-assisted hysterectomy, is a commonly performed gynecologic surgery that universally results in postoperative pain for patients. Opioid medications are helpful to control postoperative pain and are routinely given to women who undergo minimally invasive hysterectomy. However, opioid abuse is on the rise in the United States, and there is increased awareness of misuse leading to abuse, overdose, and chronic opioid use. In addition to narcotic usage, postoperative pain also has negative effects on patient satisfaction and length of stay in the post-anesthesia care unit (PACU) leading to potential hospital admission. There is existing evidence that reducing the pressure used to create the pneumoperitoneum during laparoscopic surgery may affect pain scores that patients endorse in the PACU. Due to improved postoperative pain, patients may have decreased opioid use in the PACU and at home, shorter hospital stay, and improved overall patient satisfaction. If lower pneumoperitoneum pressures during laparoscopic surgery can be shown to reduce postoperative pain, then the ultimate question becomes whether there is ability to adapt this practice of using lower pressures to maintain pneumoperitoneum. It is unclear whether physician satisfaction will be affected.

There are several publications investigating the effect of lower pneumoperitoneum pressures on postoperative pain. A systematic review in 2016 included 238 patients (three RCTs), showed pneumoperitoneum pressures of 8mmHg had a statistically significant although minimal decrease in postoperative pain compared to 12mmHg, although lower pressures were associated with worse visualization. The authors concluded that the systematic review was inconclusive and further studies were necessary. A randomized pilot study with 60 patients comparing low pressure (7mmHg) using the AirSeal System versus standard insufflation (15mmHg), showed lower postoperative shoulder pain in the group with lower pressure using the AirSeal system. Two abstracts in the Journal of Minimally Invasive Gynecology present retrospective studies showing decreased postoperative pain with lower pneumoperitoneum pressure. The first abstract is from 2015, included a sample size of 170 patients who underwent benign robotic gynecologic surgery, 85 patients in each arm (12mmHg and 15mmHg). They showed no difference in median recovery time in the PACU and significantly lower median first pain score (5 vs 6, p=.04). The second abstract is from 2018 and included a sample size of 598 patients who underwent benign robotic gynecologic surgery, 99 patients in 15mmHg arm, 100 patients in 12mmHg arm, 99 patients in 10mmHg arm, and 300 patients in 8mmHg arm. They showed lower initial pain scores with each degree of lower pressure (5.9 vs 5.4 vs 4.4 vs 3.8, p=\<.0001) and shorter hospital stays with lower pressures. They showed no difference in operative times or blood loss in the four arms. Similar studies have been done with cholecystectomy patients that have shown improved postoperative shoulder pain with lower pneumoperitoneum pressures. There is also an ongoing clinical trial that is still recruiting patients that is studying this similar comparison using 9mmHg vs 15mmHg with and without the AirSeal system.

However, the literature summarized here has never included blinding the intervention of lower pneumoperitoneum pressure to the surgeon to determine awareness of pressure and its effect on visualization and physician satisfaction.

02

Conditions studied

  • Hysterectomy
  • Pneumoperitoneum

Browse trials for

03

In context

Pneumoperitoneum

149 studies on the registry are indexed under Pneumoperitoneum; 29 are open to participants now.

This study's enrollment of 40 is below the median of 79 across 96 interventional studies indexed under Pneumoperitoneum.

Browse Pneumoperitoneum studies →

Lead sponsor

University of Arizona is the lead sponsor of 466 studies on the registry; 87 are open to participants now.

Of its 47 completed or terminated interventional studies of FDA-regulated products, 29 (62%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • female patients
  • greater than or equal to 18 years old
  • English-speaking
  • undergoing laparoscopic or robotic total hysterectomy for benign indications by one of the two minimally invasive gynecologic surgeons at Banner University Medical Center - Phoenix

Exclusion criteria

Exclusion Criteria:

  • patients with body max index >35
  • American Society of Anesthesiologists (ASA) score III or IV
  • preoperative uterine weight estimated to be greater than 500gm (measured by sonography and using the following formula: length x width x anteroposterior diameter x 0.52)
  • patients on chronic opioids for chronic pain (defined as > 3 months regular opioid use)
  • patients who refuse participation in the study
  • patients who do not provide informed consent
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
40 participants (actual)

Study arms

  • Active comparator
    1. Pneumoperitoneum pressure = 15mmHg

    1. Pneumoperitoneum will be set at 15mmHg

    Other: Pneumoperitoneum pressure = 15mmHg

  • Active comparator
    2. Pneumoperitoneum pressure = 12mmHg

    2.Pneumoperitoneum will be set at 12mmHg

    Other: Pneumoperitoneum pressure = 12mm Hg

  • Active comparator
    3. Pneumoperitoneum set at 10mmHg

    3. Pneumoperitoneum will be set at 10mmHg

    Other: Pneumoperitoneum pressure = 10mmHg

Interventions

  • OtherPneumoperitoneum pressure = 15mmHg

    Randomized pneumoperitoneum 1

  • OtherPneumoperitoneum pressure = 12mm Hg

    Randomized pneumoperitoneum 2

  • OtherPneumoperitoneum pressure = 10mmHg

    Randomized pneumoperitoneum 3

06

What researchers measure

Primary outcomes

  1. Physician Satisfaction Part 1

    Physician satisfaction questionnaire completed immediately postoperative, 3 questions in length and measured with VAS score (0-5)

    Time frame: From completion of surgery to one hour postoperative

  2. Physician Satisfaction Part 2

    Included in the physician satisfaction questionnaire is presumed pneumoperitoneum pressure, measured as 10mmHg, 12mmHg, or 15mmHg (circle one - 10mmHg, 12mmHg, 15mmHg)

    Time frame: From completion of surgery to one hour postoperative

  3. Physician Satisfaction Part 3

    Included in the physician satisfaction questionnaire are two yes/no questions on effect of pneumoperitoneum on visualization and operative time (circle one - yes, no)

    Time frame: From completion of surgery to one hour postoperative

Secondary outcomes

  1. Postoperative Pain

    Self reported pain intensity in PACU (VAS 0-10) first reported and maximum pain score, pain score at 6 hours postoperative, and pain score at 24 hours postoperative

    Time frame: From completion of surgery to 24 hours postoperative

  2. Postoperative Shoulder Pain

    Self reported shoulder pain intensity (VAS 0-10) at 6 hours postoperative and pain score at 24 hours postoperative

    Time frame: From completion of surgery to 24 hours postoperative

Other outcomes

  1. Narcotic usage

    Morphine equivalent units in PACU and at 24 hours postoperative

    Time frame: From completion of surgery to 24 hours postoperative

  2. Length of hospital stay

    Time in minutes of length of stay in hospital

    Time frame: From completion of surgery to hospital discharge time up to 7 days

  3. Patient Satisfaction

    Patient satisfaction questionnaire completed 24 hours postoperative over the phone, 2 questions in length, VAS score (0-5) on satisfaction with overall postoperative pain and shoulder postoperative pain

    Time frame: From completion of surgery to 24 hours postoperative

  4. Intraoperative Respiratory Parameters: Peak inspiratory pressure

    Peak inspiratory pressure

    Time frame: From start of surgery to end of surgery

  5. Intraoperative Respiratory Parameters: Tidal volume

    Tidal volume

    Time frame: From start of surgery to end of surgery

  6. Intraoperative Respiratory Parameters: End tidal CO2

    End tidal CO2

    Time frame: From start of surgery to end of surgery

07

Study locations

1 site
  • Banner University Medical Center Phoenix
    Phoenix, Arizona 85006, United States
08

References and documents

Publications

  • Kyle EB, Maheux-Lacroix S, Boutin A, Laberge PY, Lemyre M. Low vs Standard Pressures in Gynecologic Laparoscopy: a Systematic Review. JSLS. 2016 Jan-Mar;20(1):e2015.00113. doi: 10.4293/JSLS.2015.00113. PubMed 26955258 ↗
  • Bogani G, Uccella S, Cromi A, Serati M, Casarin J, Pinelli C, Ghezzi F. Low vs standard pneumoperitoneum pressure during laparoscopic hysterectomy: prospective randomized trial. J Minim Invasive Gynecol. 2014 May-Jun;21(3):466-71. doi: 10.1016/j.jmig.2013.12.091. Epub 2013 Dec 25. PubMed 24374246 ↗
  • Sroussi J, Elies A, Rigouzzo A, Louvet N, Mezzadri M, Fazel A, Benifla JL. Low pressure gynecological laparoscopy (7mmHg) with AirSeal(R) System versus a standard insufflation (15mmHg): A pilot study in 60 patients. J Gynecol Obstet Hum Reprod. 2017 Feb;46(2):155-158. doi: 10.1016/j.jogoh.2016.09.003. Epub 2017 Jan 30. PubMed 28403972 ↗
  • 3. Kim DK, Cheong ILY, Lee GY, Cho JH. Low pressure (8 mm Hg) pneumoperitoneum does not reduce the incidence and severity of postoperative nausea and vomiting (PONV) following gynecologic laparoscopy. Korean J Anesthesiol. 2006.
  • Topcu HO, Cavkaytar S, Kokanali K, Guzel AI, Islimye M, Doganay M. A prospective randomized trial of postoperative pain following different insufflation pressures during gynecologic laparoscopy. Eur J Obstet Gynecol Reprod Biol. 2014 Nov;182:81-5. doi: 10.1016/j.ejogrb.2014.09.003. Epub 2014 Sep 16. PubMed 25265495 ↗
  • Nasajiyan N, Javaherfourosh F, Ghomeishi A, Akhondzadeh R, Pazyar F, Hamoonpou N. Comparison of low and standard pressure gas injection at abdominal cavity on postoperative nausea and vomiting in laparoscopic cholecystectomy. Pak J Med Sci. 2014 Sep;30(5):1083-7. doi: 10.12669/pjms.305.5010. PubMed 25225531 ↗

Individual participant data

Plan to share: Yes — De-identifed individual participant data for all primary and secondary outcomes measures will be made available.

Supporting information: Study protocol, Sap, Icf, Csr, Analytic code

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 7, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04125173
Lead sponsor
University of Arizona
Responsible party
Rachael Bailey Smith (Rachael Smith, DO Fellow Minimally Invasive Gynecology, University of Arizona) — Principal investigator
First posted
Oct 14, 2019
Start date
Mar 3, 2020
Primary completion
Sep 30, 2021
Completion
Nov 30, 2021
Last update
Dec 7, 2021

Study contacts

Michael Foley, MD
study chair · Banner University Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion